O'Donovan, 1993 - Google Patents
Erythrocyte invasion by the rodent malaria Plasmodium chabaudi chabaudiO'Donovan, 1993
View PDF- Document ID
- 15768627164708177747
- Author
- O'Donovan S
- Publication year
External Links
Snippet
Erythrocyte invasion is a process essential to the survival of malaria parasites. An understanding of the mechanisms that occur during the invasion event is important, since interruption of any of these events would halt the parasite's asexual cycle and prevent …
- 210000003743 Erythrocytes 0 title abstract description 325
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bousema et al. | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination | |
| Langreth et al. | Antigenicity of the infected-erythrocyte and merozoite surfaces in Falciparum malaria. | |
| Sherman | Membrane structure and function of malaria parasites and the infected erythrocyte | |
| Pal-Bhowmick et al. | Protective properties and surface localization of Plasmodium falciparum enolase | |
| Deans et al. | Biosynthesis of a putative protective Plasmodium knowlesi merozoite antigen | |
| Biggs et al. | Knob-independent cytoadherence of Plasmodium falciparum to the leukocyte differentiation antigen CD36. | |
| JPS60502206A (en) | Methods and materials for protective immune responses to malaria infection | |
| Reese et al. | Inhibition of the in vitro growth of Plasmodium falciparum: I. The effects of immune serum and purified immunoglobulin from owl monkeys | |
| Kara et al. | Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane | |
| Wahlgren et al. | Molecular mechanisms and biological importance of Plasmodium falciparum erythrocyte rosetting | |
| Franssen et al. | Characterisation of erythrocyte invasion by Babesia bovis merozoites efficiently released from their host cell after high-voltage pulsing | |
| Wyler | Malaria: host-pathogen biology | |
| Howard et al. | Characterization of surface proteins and glycoproteins on red blood cells from mice infected with haemosporidia: Plasmodium berghei infections of BALB/c mice | |
| Nguyen et al. | Stage-dependent localization of a novel gene product of the malaria parasite, Plasmodium falciparum | |
| Mehrizi et al. | IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran | |
| O'Donovan | Erythrocyte invasion by the rodent malaria Plasmodium chabaudi chabaudi | |
| Rungruang et al. | Erythrocyte surface glycosylphosphatidyl inositol anchored receptor for the malaria parasite | |
| Persson | Erythrocyte invasion and functionally inhibitory antibodies in Plasmodium falciparum malaria | |
| Sauerwein et al. | Sexual and sporogonic stage antigens | |
| WO2003069342A1 (en) | A method of screening | |
| McColm et al. | Release of radio-isotope labelled antigens from Plasmodium knowlesi during merozoite re-invasion in vitro | |
| Bigeard | Development of in vitro models for the study of the human CD8 T cell response to Plasmodium liver stage | |
| Sharma et al. | Protective Properties and Surface | |
| WO2001013923A1 (en) | Malaria gpi anchors as vaccines anti-parasitic drugs and for use in diagnostics | |
| Freeman | Malarial infections in laboratory mice |